Trifecta-Lung cfDNA-MMDx Study

Description

Demonstrate the relationship between dd-cfDNA levels and HLA antibodies in blood transplant recipient and Demonstrate the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from lung transplants.

Conditions

Lung Transplantation

Study Overview

Study Details

Study overview

Demonstrate the relationship between dd-cfDNA levels and HLA antibodies in blood transplant recipient and Demonstrate the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from lung transplants.

Trifecta-Lung cfDNA-MMDx Study: Comparing the Dd-cfDNA Test to MMDx Microarray Test and Central HLA Antibody Test

Trifecta-Lung cfDNA-MMDx Study

Condition
Lung Transplantation
Intervention / Treatment

-

Contacts and Locations

Gainesville

Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, College of Medicine, Gainesville, Florida, United States, 32610

Dallas

BAYLOR SCOTT & WHITE RESEARCH INSTITUTE , 3409 Worth Street, Dallas, Texas, United States, 75246

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    University of Alberta,

    Philip F Halloran, MD PhD, PRINCIPAL_INVESTIGATOR, Alberta Transplant Applied Genomics Centre, University of Alberta

    Study Record Dates

    2027-12